These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12556014)

  • 21. Airmax: a multi-dose dry powder inhaler.
    Keating GM; Faulds D
    Drugs; 2002; 62(13):1887-95; discussion 1896-7. PubMed ID: 12215059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formoterol delivered via a new multi-dose dry powder inhaler (Certihaler) is as effective and well tolerated as the formoterol dry powder inhaler (Aerolizer) in children with persistent asthma.
    Chuchalin AG; Manjra AI; Rozinova NN; Skopková O; Cioppa GD; Till D; Kaiser G; Fashola T; Kottakis J
    J Aerosol Med; 2005; 18(1):63-73. PubMed ID: 15741775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pharmacokinetic/pharmacodynamic study comparing arformoterol tartrate inhalation solution and racemic formoterol dry powder inhaler in subjects with chronic obstructive pulmonary disease.
    Kharidia J; Fogarty CM; Laforce CF; Maier G; Hsu R; Dunnington KM; Curry L; Baumgartner RA; Hanrahan JP
    Pulm Pharmacol Ther; 2008 Aug; 21(4):657-62. PubMed ID: 18501650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of formoterol delivered via a new multidose dry powder inhaler (Certihaler) in adolescents and adults with persistent asthma.
    LaForce C; Prenner BM; Andriano K; Lavecchia C; Yegen U
    J Asthma; 2005 Mar; 42(2):101-6. PubMed ID: 15871441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D; Vicaut E; Lefrançois G;
    Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPD.
    Cazzola M; Santus P; Matera MG; Carlucci P; Belloli E; Di Marco F; Centanni S
    Respir Med; 2003 May; 97(5):458-62. PubMed ID: 12735660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similar efficacy following four weeks treatment of asthmatics with formoterol 12 micrograms b.d. delivered by two different dry powder inhalers: differences in inhaler handling.
    Eliraz A; Ramirez-Rivera A; Ferranti P; Holzer R; García JM; Turcotte C; Rapatz G; Pfister P; Overend T; Kottakis J
    Int J Clin Pract; 2001 Apr; 55(3):164-70. PubMed ID: 11351769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of formoterol Turbuhaler at cumulative dose of 90 microg in patients with acute bronchial obstruction.
    Malolepszy J; Böszörményi Nagy G; Selroos O; Larsso P; Brander R
    Eur Respir J; 2001 Dec; 18(6):928-34. PubMed ID: 11829098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort Turbuhaler) for the treatment of asthma.
    Rosenhall L; Elvstrand A; Tilling B; Vinge I; Jemsby P; Ståhl E; Jerre F; Bergqvist PB
    Respir Med; 2003 Jun; 97(6):702-8. PubMed ID: 12814158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma.
    Lalloo UG; Malolepszy J; Kozma D; Krofta K; Ankerst J; Johansen B; Thomson NC
    Chest; 2003 May; 123(5):1480-7. PubMed ID: 12740264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
    Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peak inspiratory flow rate after methacholine challenge in asthmatic patients and its impact on the effect of formoterol via different inhalers.
    Haidl P; Schmidt F; Wiese C; Koehler D
    J Aerosol Med; 2006; 19(3):364-71. PubMed ID: 17034311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma.
    Buhl R; Creemers JP; Vondra V; Martelli NA; Naya IP; Ekström T
    Respir Med; 2003 Apr; 97(4):323-30. PubMed ID: 12693793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time course of bronchodilating effect of inhaled formoterol, a potent and long acting sympathomimetic.
    Derom EY; Pauwels RA
    Thorax; 1992 Jan; 47(1):30-3. PubMed ID: 1539141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bronchodilator effect of single-dose formoterol administered by pressurized metered-dose inhaler in children with asthma aged 6 to <12 years receiving budesonide.
    Berger WE; Gillen M; Eckerwall G; Uryniak T; Trudo FJ; Lampl KL
    Allergy Asthma Proc; 2014; 35(2):134-40. PubMed ID: 24717790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD.
    Reisner C; Pearle J; Kerwin EM; Rose ES; Darken P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1965-1977. PubMed ID: 29950826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients.
    Molimard M; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():28-34. PubMed ID: 15915010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.